Review Article
Primary vitreoretinal lymphoma: recent advances and literature review
Annals of Lymphoma
2020;
4:
17
(30 December 2020)
Review Article
Radiation therapy of extranodal marginal zone lymphomas
Annals of Lymphoma
2020;
4:
16
(30 December 2020)
Review Article
Pathology of extranodal marginal zone lymphoma at different anatomic sites
Annals of Lymphoma
2020;
4:
15
(30 December 2020)
Review Article
Primary central nervous system lymphoma: consolidation strategies
Annals of Lymphoma
2020;
4:
14
(30 December 2020)
Review Article
Present role and future perspective of PET-CT in marginal zone lymphoma
Annals of Lymphoma
2020;
4:
13
(30 December 2020)
Review Article
Tailored treatment in mantle cell lymphoma
Annals of Lymphoma
2020;
4:
12
(30 December 2020)
Review Article
Report from the Lymphoma Research Foundation Adolescent and Young Adult (AYA) Lymphoma Scientific Workshop, May 2019
Annals of Lymphoma
2020;
4:
11
(30 December 2020)
Review Article
The B cell receptor in marginal zone lymphoma ontogeny and evolution
Annals of Lymphoma
2020;
4:
10
(30 December 2020)
Original Article
Effectiveness and safety of pembrolizumab as bridging to hematopoietic stem cell transplantation in relapsed and refractory classical Hodgkin’s lymphoma: a retrospective observational study
Annals of Lymphoma
2020;
4:
9
(30 December 2020)
Review Article
Mucosa-associated lymphoid tissue lymphoma of various sites: common molecular mechanisms but different players
Annals of Lymphoma
2020;
4:
8
(30 September 2020)
Review Article
Targeting pathogenic mechanisms in marginal zone lymphoma: from concepts and beyond
Annals of Lymphoma
2020;
4:
7
(30 September 2020)
Review Article
Prognostic factors and risk of transformation in marginal zone lymphoma
Annals of Lymphoma
2020;
4:
6
(30 September 2020)
Review Article
A narrative review of survival normalization in non-Hodgkin lymphoma: useful for better patient counselling and an endpoint for clinical trials?
Annals of Lymphoma
2020;
4:
5
(30 September 2020)
Review Article
Minimal residual disease (MRD) in mantle cell lymphoma
Annals of Lymphoma
2020;
4:
4
(30 June 2020)
Editorial
Growing (up) together: understanding lymphoma in the adolescent and young adult population
Annals of Lymphoma
2020;
4:
3
(30 June 2020)
Review Article
Recent advances in the first-line treatment of mantle cell lymphoma
Annals of Lymphoma
2020;
4:
2
(31 March 2020)
Review Article
Targeting CDK4/6 in mantle cell lymphoma
Annals of Lymphoma
2020;
4:
1
(31 March 2020)
Editorial
Better understanding and new challenges in high grade lymphomas
Annals of Lymphoma
2019;
3:
13
(18 December 2019)
Case Report
PD-L1 expression and response to nivolumab in a case of relapsed/refractory lymphomatoid granulomatosis
Annals of Lymphoma
2019;
3:
12
(18 December 2019)
News
Application of the CARE guideline as reporting standard in the Annals of Lymphoma
Annals of Lymphoma
2019;
3:
11
(12 December 2019)
Review Article
New drugs for the management of relapsed or refractory diffuse large B-cell lymphoma
Annals of Lymphoma
2019;
3:
10
(27 November 2019)
Review Article
A survey of the therapeutic landscape in peripheral T-cell lymphomas: the importance of expert hematopathology review in the era of targeted therapies and precision medicine
Annals of Lymphoma
2019;
3:
9
(21 November 2019)
Review Article
Front-line therapy in elderly patients with mantle cell lymphoma
Annals of Lymphoma
2019;
3:
8
(25 July 2019)
Review Article
Risk stratification and management algorithms for patients with diffuse large B-cell lymphoma and CNS involvement
Annals of Lymphoma
2019;
3:
7
(18 July 2019)
Review Article
Immunologic treatment strategies in mantle cell lymphoma: checkpoint inhibitors, chimeric antigen receptor (CAR) T-cells, and bispecific T-cell engager (BiTE) molecules
Annals of Lymphoma
2019;
3:
6
(27 May 2019)